Drug therapy: immunosuppressive agents (second of two parts).
D000963:Antimetabolites / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001379:Azathioprine / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D004359:Drug Therapy, Combination; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use* / Q000633:toxicity; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy; D011687:Purines / Q000627:therapeutic use; D013438:Sulfhydryl Compounds / Q000627:therapeutic use
D000963:Antimetabolites; D005493:Folic Acid Antagonists; D007166:Immunosuppressive Agents; D011687:Purines; D013438:Sulfhydryl Compounds; D001379:Azathioprine; D008727:Methotrexate